Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Mr. Stephen P. Ewald J.D.

Chief Compliance Officer, General Counsel & Corporate Secretary

Brandon  Ebken

Chief Information Officer

Mr. Jesse J. Geiger BBA, CPA

President

Ms. Susan E. Burwig BSN, MA

Executive Vice President of Operations

Ms. Lauren  Morris

Associate Director of Investors Relations

Mr. Reinilde  Heyrman M.D.

Chief Medical Officer of Medical Department

Mr. Todd  Meyers

Vice President of Business Development & Marketing

Mr. Kevin M. Brady

Chief Financial Officer & Treasurer

John T. Wynne MBA

Senior Vice President of Commercial Operations & Clinical Pharmacology Unit

Dr. August James Troendle M.D.

Chairman & Chief Executive Officer

Medpace Holdings, Inc.

Medpace Holdings, Inc. Management-Struktur

Informationen zum Management